North American High throughput screening Market Research Report
- Report Code: HI 1001
- Publish Date: Upcoming
The North American high-throughput screening market is mainly driven by target identification & validation, efficacy & safety screening, and monitoring of cell-based activity. The market was valued at $6,454.3 million in 2013, and is expected to grow at a CAGR of 7.0%, to reach $9,046.8 million by 2018. Furthermore, the high rate of utilization of high-throughput screening technologies by pharmaceutical companies, for the screening of compound libraries, has led to the growth of this market.
The report analyzes the North American high-throughput screening market, primarily categorized by technology, product, end-user, and application. The technology segment is further categorized into ultra-high-throughput screening (uHTS), cell-based assay, lab-on-a-chip, label-free technology, and bioinformatics. By product, the HTS market is segmented into instrument, consumable/reagent, and software & service. The end-user segment categorizes the high-throughput screening market into pharmaceutical, biotechnology, academia & government, and contract research organization. The application segment of the high-throughput screening comprises target identification, primary screening, toxicology, and stem cell biology.
In 2013, the cell-based assay market segment had the largest share of 57.1%, with a market value of $3.3 billion, in the North American high-throughput screening market. This segment is expected to reach $4.5 billion in 2018, at a CAGR of 6.2% from 2013 to 2018. This large share can be attributed to the high usage of cell-based high-throughput screening methods of compound screening. The label-free technology segment is expected to grow at a rapid pace, owing to their increasing adoption rate in HTS laboratories.
The North American high-throughput screening market is mainly driven by the adoption of open innovation models by pharmaceutical companies to increase the use of high-throughput screening, increasing drug discovery initiatives by academic and government institutions to boost the demand for high-throughput screening products, and increasing capital investments in high-throughput screening technology by major firms such as PerkinElmer (U.S.), Beckman Coulter (U.S.), and Tecan Group (Switzerland), among others. Furthermore, private equity firms and venture capitalists are increasingly investing in countries, such as the U.S, Canada, and Mexico, thereby driving the growth of the North American HTS market.
The report also provides an extensive competitive landscaping of the leading companies operating in this market. The major players in the market include Agilent Technologies, Inc. (U.S.), PerkinElmer (U.S.), Beckman Coulter, Inc. (a subsidiary of Danaher Corporation) (U.S.), Sigma-Aldrich Corporation (U.S.), and Tecan Group (Switzerland), among others. Furthermore, segment and country-specific company shares, news & deals, M&A, segment-specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report.
Customization Options
Along with the market data, you can also customize the MMM assessments to meet your company’s specific needs. Customize to get a comprehensive summary of the industry standards and deep-dive analysis of the following parameters:
Product Analysis
- Usage pattern (in-depth trend analysis) of products (segment-wise)
- Product matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub-segment levels
- End-user adoption rate analysis of the products (segment-wise and country-wise)
- Comprehensive coverage of product approvals, pipeline products, and product recalls
Volume Data
- Data related to end-user segments of the market, such as pharmaceutical, biotechnology, academia and government, and contract research organization
Researchers Perception Analysis
- Fast turn-around analysis of researchers’ responses to market events and trends
- Pattern analysis of usage of ultra-high-throughput screening (uHTS), cell-based assay, lab-on-a-chip, label-free technology, and bioinformatics by researchers
- Researchers’ opinions about products from different companies
Brand/Product Perception Matrix
- Comprehensive study of customers’ perception and behavior through our in-built social connect tool checking the vitality and tonality of blogs
- An analysis of overall brand usage and familiarity and brand advocacy distribution (detractor/neutral/familiar)
Pricing Trends
- Cost analysis of ultra-high-throughput screening (uHTS), cell-based assay, lab-on-a-chip, label-free technology, and bioinformatics in major countries of the region
- Investments made in the North American high-throughput screening market
Competitive Intelligence
- Company share analysis of the top players in the North American HTS market
- Crucial developments and strategies that companies inculcate in their portfolios
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
